Cite Filings / MTRI
Feed Companies Filings Check
Sign in

CIK 0001728328

  • Emerging growth company

InMed Pharmaceuticals Inc.

Sign in to watch
Ticker
MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 604-669-7207
Business address
C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Filings Financials Insiders Search text
All 537 Financials 203 Shareholder Meetings 8 Executive Compensation 190 Insider Trading 160 Beneficial Ownership Interest 28 Business Combinations 186 Public Offerings 82 Mutual Funds and ETFs 6 Others 51
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2025-11-03
  3. PRE 14A Proxy Proxy Statement (Preliminary) 2025-10-24
  4. DEF 14A Proxy Proxy Statement 2025-05-16
  5. PRE 14A Proxy Proxy Statement (Preliminary) 2025-04-29
  6. DEF 14A Proxy Proxy Statement 2024-10-28
  7. DEF 14A Proxy Proxy Statement 2023-10-27
  8. DEF 14A Proxy Proxy Statement 2022-10-28
  9. DEF 14A Proxy Proxy Statement 2021-10-28

Page 1 of 1 · 8 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…